BUDGET IMPACT OF AN EXTENDED HALF LIFE RECOMBINANT FVIII THERAPY FOR A HYPOTHETICAL POPULATION OF SEVERE HEMOPHILIA A PATIENTS IN AN INSURED POPULATION IN THE UNITED STATES
May 1, 2016, 00:00 AM
10.1016/j.jval.2016.03.1039
https://www.valueinhealthjournal.com/article/S1098-3015(16)01107-4/fulltext
Section Title :
Systemic Disorders/Conditions - Cost Studies
Section Order :
885
First Page :
A243
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01107-4&doi=10.1016/j.jval.2016.03.1039